An exploratory PET/MR radiomics framework for preoperative prediction of HER2 status and metastatic burden in colorectal cancer
Year: 2026
Type: article
Study design: Observational Study
Abstract: Introduction: Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) status and metastatic burden in colorectal cancer remains challenging. Multimodal positron emission tomography (PET)/magnetic resonance (MR) radiomics offers an opportunity for integrated molecular and metastatic characterization. Objective: To develop and internally validate an exploratory PET/MR radiomics framework for the preoperative prediction of HER2 status and metastatic burden (non-regional lymph nodes) in colorectal cancer (CRC) patients. Methods: This retrospective study incorporated 61 samples with pathologically confirmed CRC who underwent preoperative 18F-fluorodeoxyglucose PET/MR imaging. HER2 positivity was defined according to the refined HER2 Amplification for CRC Enhanced Stratification criteria. Metastatic burden was categorized into three groups based on preoperative imaging: non-metastatic, regional lymph node metastasis, and distant metastasis. Tumor regions were manually segmented on PET, T1- and T2-weighted imaging (T1WI, T2WI), and 2,264 radiomic features were extracted from each imaging modality. Feature selection was performed using a comprehensive multi-step pipeline. An extreme gradient boosting (XGBoost)-based model was then developed and internally validated via 5-fold cross-validation, with performance metrics reported as mean ± standard deviation. Results: For HER2 status prediction, the multimodal combined XGBoost model demonstrated superior performance compared to single-modality models, yielding a mean AUC of 0.9214 ± 0.0779. For metastatic burden prediction, the combined model further excelled, yielding an AUC of 0.827 ± 0.136. SHapley Additive exPlanations analysis revealed imaging signatures for the two prediction tasks. HER2 status prediction was primarily driven by texture-related features, particularly those derived from the Gray-Level Run Length Matrix, Gray-Level Co-occurrence Matrix, and First-order matrices, whereas metastatic burden prediction relied mainly on multiscale texture descriptors from the first-order, Neighborhood Gray-Tone Difference Matrix, and Gray-Level Dependence Matrix. Conclusion: PET/MR radiomics offers an exploratory approach for future risk stratification in CRC, although independent validation is required to confirm clinical utility.
Authors: Zengbei Yuan(Conceptualization, Data curation, Investigation, Writing – original draft), Kun Wang(Data curation, Investigation, Writing – original draft), Wen Jiang(Data curation, Investigation, Writing – original draft), Zhixian Tang(Formal analysis, Validation), Xing Chen(Formal analysis, Validation), Weilun Wang(Formal analysis, Validation), Yihong Yang(Data curation, Visualization), Zirong Zhou(Data curation, Visualization), Jun Zhao(Data curation, Visualization), Qingqing Huang(Funding acquisition, Methodology, Supervision, Writing – review & editing), Na Qi(Funding acquisition, Methodology, Supervision, Writing – review & editing)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Award: G2229998227
OpenAlex ID: W7235108222
